IDEXX Laboratories, Inc.
Capitalización de mercado
$43.1B
Puesto mundial
#275
Máximo histórico
$53.4B
2025-12-31
Crecimiento total
+0%
desde 2026
Market Cap Context
- Larger than 25% of the 367 companies we track (globally).
- Equivalent to 0.1% of United States's GDP (2025 data).
- Just above: #274 BYD ($43.1B)
- Just below: #276 Ambev S.A. ($42.9B)
- Best year: 1995 (+161%). Worst year: 1997 (-56%).
IDEXX Laboratories, Inc. Financial Breakdown (FY 2025)
Source: Yahoo Finance — IDXX annual filings (2025) →$4.3B revenue · $1.4B operating income · $1.1B net income
- ●Operating margin: 31.6% on $4.3B in revenue.
- ●R&D is 5.8% of revenue ($0.3B).
- ●Net income margin: 24.6% — $1.1B in profit.
- ●Free cash flow: $1.0B (24.2% of revenue).
Cost / Operating Expenses
Total operating expenses $2.9B
Total
$2.9B
Capital Expenditures
$0.1B
This fiscal year (near-total AI infrastructure buildout)
Free Cash Flow
$1.0B
Trailing twelve months
Figures rounded from the annual SEC filing. Unaudited. For informational purposes only, not investment advice.
Acerca de IDEXX Laboratories, Inc.
IDEXX Laboratories, Inc. is an American multinational corporation engaged in the development, manufacture, and distribution of products and services for the companion animal veterinary, livestock and poultry, water testing, and dairy markets. Incorporated in 1983 by David Evans Shaw, the company is headquartered in Westbrook, Maine, and in Hoofddorp, Netherlands for its EMEA divisions. IDEXX offers products to customers in over 175 countries around the world and employs about 11,000 people in full-and part-time positions.
Historial de capitalización de mercado de IDEXX Laboratories, Inc. (2026–2026)
IDEXX Laboratories, Inc. vs Sector Peers by Market Cap
Comparar IDEXX Laboratories, Inc.
Historial de clasificación
| Año | Capitalización de mercado | Puesto | Variación interanual |
|---|---|---|---|
| 2026 | $43.1B | #275(↓35) | -19.3% |
| 2025 | $53.4B | #240(↑55) | +63.6% |
| 2024 | $32.6B | #295(↓57) | -25.5% |
| 2023 | $43.8B | #238(↑23) | +36.1% |
| 2022 | $32.2B | #261(↓63) | -38.0% |
| 2021 | $51.9B | #198(↑10) | +31.7% |
| 2020 | $39.4B | #208(↑67) | +91.4% |
| 2019 | $20.6B | #275(↓5) | +40.4% |
| 2018 | $14.7B | #270(↑9) | +19.0% |
| 2017 | $12.3B | #279(↓1) | +33.4% |
| 2016 | $9.3B | #278(↑6) | +60.8% |
| 2015 | $5.8B | #284(↓3) | -1.6% |
| 2014 | $5.8B | #281(↑3) | +39.4% |
| 2013 | $4.2B | #284(↓6) | +14.6% |
| 2012 | $3.7B | #278(↓7) | +20.6% |
| 2011 | $3.0B | #271(↑1) | +11.2% |
| 2010 | $2.7B | #272(↓4) | +29.5% |
| 2009 | $2.1B | #268(↓3) | +48.1% |
| 2008 | $1.4B | #265(↓1) | -38.5% |
| 2007 | $2.3B | #264(↓4) | +47.9% |
| 2006 | $1.6B | #260(↓1) | +10.2% |
| 2005 | $1.4B | #259(↓9) | +31.9% |
| 2004 | $1.1B | #250(↓3) | +18.0% |
| 2003 | $912.7M | #247(↓5) | +40.9% |
| 2002 | $647.8M | #242(↓1) | +15.2% |
| 2001 | $562.2M | #241(↓13) | +29.6% |
| 2000 | $433.9M | #228(↓36) | +36.4% |
| 1999 | $318.0M | #192(↓13) | -40.1% |
| 1998 | $530.6M | #179(↓6) | +68.8% |
| 1997 | $314.3M | #173(↓19) | -55.7% |
| 1996 | $709.9M | #154(↓18) | -23.4% |
| 1995 | $926.9M | #136(↓4) | +161.1% |
| 1994 | $355.0M | #132 |
Otras empresas del sector Salud
Preguntas frecuentes
What is IDEXX Laboratories, Inc.'s market cap?
IDEXX Laboratories, Inc. (IDXX) has a market capitalization of $43.1B, making it the #275 largest company in the world by market cap.
What was IDEXX Laboratories, Inc.'s highest market cap?
IDEXX Laboratories, Inc.'s all-time high market cap was $53.4B, reached in 2025-12-31. Its highest rank was #240 in 2025.
What sector is IDEXX Laboratories, Inc. in?
IDEXX Laboratories, Inc. is in the Healthcare sector, specifically the Diagnostics & Research industry. It is based in United States.
How has IDEXX Laboratories, Inc.'s market cap changed over time?
IDEXX Laboratories, Inc. has been tracked since 2026. Its market cap has grown by 0% from $43.1B in 2026 to $43.1B today.